News & Updates
Filter by Specialty:
Tenofovir alafenamide safe to use in breastfeeding mothers with CHB
The first human pharmacokinetic study of tenofovir alafenamide (TAF; commercially sold as Vemlidy) monotherapy in breastfeeding women with chronic hepatitis B (CHB) has found low concentrations of TAF and tenofovir in the breastmilk, with negligible exposure to infants.
Tenofovir alafenamide safe to use in breastfeeding mothers with CHB
16 Nov 2021
Low carbohydrate diet lowers risk of MetS, remnant cholesterol in prostate cancer
A low carbohydrate diet (LCD) may substantially reduce the risk of metabolic syndrome (MetS) and remnant cholesterol in patients with prostate cancer, a recent study has shown.
Low carbohydrate diet lowers risk of MetS, remnant cholesterol in prostate cancer
16 Nov 2021
TiNO-coated stent maintains edge over drug-eluting stent for ACS
The 3-year outcomes of the TIDES-ACS* trial continued to reflect favourable outcomes with the titanium-nitride-oxide (TiNO)-coated bioactive stent compared with a platinum-chromium-based biodegradable-polymer everolimus-eluting stent (EES) for patients with acute coronary syndrome (ACS).
TiNO-coated stent maintains edge over drug-eluting stent for ACS
16 Nov 2021
Lower healthcare utilization amid COVID-19 foreshadows looming health crisis in PH
The coronavirus disease 2019 (COVID-19) pandemic has disrupted healthcare utilization in the Philippines, leading to lower rates of admission and procedures for certain types of disease, according to a recent study.
